Does Rallies show Form 4 insider transactions for ACET?

Yes. Rallies tracks ACET insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ACET research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ACET. It does not provide personalized investment advice.

ACET (Adicet Bio, Inc. Common Stock) Stock Analysis - Insider Trades

Adicet Bio, Inc. Common Stock (ACET) is a publicly traded Healthcare sector company. As of May 21, 2026, ACET trades at $7.95 with a market cap of $70.11M and a P/E ratio of -0.79. ACET moved +7.59% today. Year to date, ACET is -4.79%; over the trailing twelve months it is -35.28%. Its 52-week range spans $6.01 to $24.64. Analyst consensus is strong buy with an average price target of $34.83. Rallies surfaces ACET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ACET stock inside the company?

Recent ACET insider activity includes ORBIMED ADVISORS LLC sold 32.52K, ORBIMED ADVISORS LLC sold 40.42K, ORBIMED ADVISORS LLC sold 29.32K, ORBIMED ADVISORS LLC sold 2.40K, and RA CAPITAL MANAGEMENT, L.P. bought 74.75K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ACET Key Metrics

Key financial metrics for ACET
Metric	Value
Price	$7.95
Market Cap	$70.11M
P/E Ratio	-0.79
EPS	$-9.80
Dividend Yield	0.00%
52-Week High	$24.64
52-Week Low	$6.01
Volume	0
Avg Volume	0
Revenue (TTM)	$682.93M
Net Income	$-346.15M
Gross Margin	12.76%

Recent ACET Insider Trades

ORBIMED ADVISORS LLC sold 32.52K (~$204.57K) on Apr 8, 2026.
ORBIMED ADVISORS LLC sold 40.42K (~$263.51K) on Apr 8, 2026.
ORBIMED ADVISORS LLC sold 29.32K (~$191.45K) on Apr 7, 2026.
ORBIMED ADVISORS LLC sold 2.40K (~$15.31K) on Apr 7, 2026.
RA CAPITAL MANAGEMENT, L.P. bought 74.75K (~$543.44K) on Feb 20, 2026.

Latest ACET News

Adicet Bio doubles prula-cel enrollment to 20+ patients, secures $74.8M and FDA outpatient dosing — Jan 7, 2026

ACET Analyst Consensus

7 analysts cover ACET: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.83.

Common questions about ACET

Who is trading ACET stock inside the company?: Recent ACET insider activity includes ORBIMED ADVISORS LLC sold 32.52K, ORBIMED ADVISORS LLC sold 40.42K, ORBIMED ADVISORS LLC sold 29.32K, ORBIMED ADVISORS LLC sold 2.40K, and RA CAPITAL MANAGEMENT, L.P. bought 74.75K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ACET?: Yes. Rallies tracks ACET insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ACET research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ACET. It does not provide personalized investment advice.